Author details

Full Name

Andras Heczey

Affiliation

ORCID

Career Start Year

2012

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37867409	A comprehensive analysis of neuroblastoma incidence, survival, and racial and ethnic disparities from 2001 to 2019.		2024
36609146	Targeting Lin28 axis enhances glypican-3-CAR T cell efficacy against hepatic tumor initiating cell population.	Mol Ther	2023
37188782	Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results.		2023
35325065	Long-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECs.	Blood	2022
35591805	Incidence and 5-year survival of children and adolescents with hepatoblastoma in the United States.	Pediatric Blood and Cancer	2022
34366130	Integration of a dedicated management protocol in the care of pediatric liver cancer: From specialized providers to complication reduction.	Journal of Pediatric Surgery	2022
32979013	Liver transplant in a recently COVID-19 positive child with hepatoblastoma.	Pediatr Transplant	2021
32425060	Pediatric Oncology Patients With Vincristine-Induced Recurrent Laryngeal Nerve Palsy: Two Case Reports and a Brief Review of Literature.	Ear, Nose and Throat Journal	2021
33769387	Transarterial Radioembolization Treatment as a Bridge to Surgical Resection in Pediatric Hepatocellular Carcinoma.	Journal of Pediatric Hematology/Oncology	2021
32729196	Is high-risk neuroblastoma induction chemotherapy possible without G-CSF? A pilot study of safety and treatment delays in the absence of primary prophylactic hematopoietic growth factors.	Pediatr Blood Cancer	2020
31953246	Glypican-3-Specific CAR T Cells Coexpressing IL15 and IL21 Have Superior Expansion and Antitumor Activity against Hepatocellular Carcinoma.	Cancer Immunology Research	2020
31729153	Agenesis of the corpus callosum and hepatoblastoma.	American Journal of Medical Genetics, Part A	2020
33046868	Anti-GD2 CAR-NKT cells in patients with relapsed or refractory neuroblastoma: an interim analysis.	Nature Medicine	2020
31337604	Alliance of the Titans: An Effective Combination of a TKI with CAR T Cells.	Molecular Therapy	2019
30977242	Characterization of pediatric hepatocellular carcinoma reveals genomic heterogeneity and diverse signaling pathway activation.	Pediatr Blood Cancer	2019
31484667	NKT Cells Coexpressing a GD2-Specific Chimeric Antigen Receptor and IL15 Show Enhanced Persistence and Antitumor Activity against Neuroblastoma.	Clinical Cancer Research	2019
30676520	Predisposing Conditions to Pediatric Hepatocellular Carcinoma and Association With Outcomes: Single-center Experience.	Journal of Pediatric Gastroenterology and Nutrition	2019
29334532	Cost-effectiveness and Improved Parent and Provider Satisfaction With Outpatient Management of Pediatric Oncology Patients, With Low-risk Fever and Neutropenia.	J Pediatr Hematol Oncol	2018
28937543	Cholangiocarcinoma Among Children and Adolescents: A Review of the Literature and Surveillance, Epidemiology, and End Results Program Database Analysis.	Journal of Pediatric Gastroenterology and Nutrition	2018
28837514	Fatal Central Nervous System Post-Transplant Lymphoproliferative Disease in a Patient Who Underwent Liver Transplantation for Hepatoblastoma.	Journal of Pediatric Gastroenterology and Nutrition	2018
30470379	50 Years Ago in The Journal of Pediatrics: Survival of Children with Neuroblastoma Treated with Combination Chemotherapy.	J Pediatr	2018
27775819	Genomic analysis of hepatoblastoma identifies distinct molecular and prognostic subgroups.	Hepatology	2017
28602436	CAR T Cells Administered in Combination with Lymphodepletion and PD-1 Inhibition to Patients with Neuroblastoma.	Molecular Therapy	2017
28347528	Vascular invasion is a prognostic indicator in hepatoblastoma.	Journal of Pediatric Surgery	2017
28856237	T Cell-Activating Mesenchymal Stem Cells as a Biotherapeutic for HCC.	Molecular Therapy - Oncolytics	2017
28902076	Therapy-related Acute Leukemia With Mixed Phenotype and Novel t(1: 6)(q25;p23) After Treatment for High-risk Neuroblastoma.	Journal of Pediatric Hematology/Oncology	2017
29108844	Liver transplantation for primary hepatic malignancies of childhood: The UNOS experience.	Journal of Pediatric Surgery	2017
27530312	Redirecting T Cells to Glypican-3 with 4-1BB Zeta Chimeric Antigen Receptors Results in Th1 Polarization and Potent Antitumor Activity.	Human Gene Therapy	2017
28154831	Targeting -Acetyl-GD2 Ganglioside for Cancer Immunotherapy.	Journal of Immunology Research	2017
27183388	CD62L+ NKT cells have prolonged persistence and antitumor activity in vivo.	Journal of Clinical Investigation	2016
26925712	Undifferentiated Embryonal Sarcoma of the Liver (UESL): A Single-Center Experience and Review of the Literature.	Journal of Pediatric Hematology/Oncology	2016
26332566	IMAGES IN CLINICAL MEDICINE. Osteopetrosis and Erlenmeyer-Flask Deformity.	New England Journal of Medicine	2015
25598116	Health disparities are important determinants of outcome for children with solid tumor malignancies.	Journal of Pediatric Surgery	2015
25049283	Invariant NKT cells with chimeric antigen receptor provide a novel platform for safe and effective cancer immunotherapy.	Blood	2014
24333408	Advances in chimeric antigen receptor immunotherapy for neuroblastoma.		2013
22565311	IL-15 protects NKT cells from inhibition by tumor-associated macrophages and enhances antimetastatic activity.	Journal of Clinical Investigation	2012